Page last updated: 2024-08-21

adamantane and Colitis Gravis

adamantane has been researched along with Colitis Gravis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Kim, JW; Kim, SY	1
Ferrante, M; Sabino, J	1
Bertelsen, K; Feagan, BG; Johanns, J; Lichtenstein, GR; Marano, C; O'Brien, CD; Panes, J; Sandborn, WJ; Sands, BE; Strauss, R; Szapary, P; Vermeire, S; Yang, Z; Zhang, H	1

Reviews

2 review(s) available for adamantane and Colitis Gravis

Article	Year
The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment. International journal of molecular sciences, 2021, Oct-20, Volume: 22, Issue:21 Topics: Adamantane; Colitis; Colitis, Ulcerative; Crohn Disease; Heterocyclic Compounds, 3-Ring; Humans; Inflammatory Bowel Diseases; Janus Kinase Inhibitors; Janus Kinases; Niacinamide; Piperidines; Pyridines; Pyrimidines; Pyrroles; Triazoles	2021
Efficacy of JAK inhibitors in Ulcerative Colitis. Journal of Crohn's & colitis, 2020, Aug-01, Volume: 14, Issue:Supplement Topics: Adamantane; Colitis, Ulcerative; Heterocyclic Compounds, 3-Ring; Humans; Janus Kinase Inhibitors; Niacinamide; Piperidines; Pyrimidines; Treatment Outcome	2020

Article

Year

The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment.

International journal of molecular sciences, 2021, Oct-20, Volume: 22, Issue:21

Topics: Adamantane; Colitis; Colitis, Ulcerative; Crohn Disease; Heterocyclic Compounds, 3-Ring; Humans; Inflammatory Bowel Diseases; Janus Kinase Inhibitors; Janus Kinases; Niacinamide; Piperidines; Pyridines; Pyrimidines; Pyrroles; Triazoles

2021

Efficacy of JAK inhibitors in Ulcerative Colitis.

Journal of Crohn's & colitis, 2020, Aug-01, Volume: 14, Issue:Supplement

Topics: Adamantane; Colitis, Ulcerative; Heterocyclic Compounds, 3-Ring; Humans; Janus Kinase Inhibitors; Niacinamide; Piperidines; Pyrimidines; Treatment Outcome

2020

Trials

1 trial(s) available for adamantane and Colitis Gravis

Article	Year
Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study. Journal of Crohn's & colitis, 2018, Nov-09, Volume: 12, Issue:10 Topics: Adamantane; Administration, Oral; Adult; Biomarkers; C-Reactive Protein; Colitis, Ulcerative; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Intestinal Mucosa; Janus Kinase Inhibitors; Male; Middle Aged; Niacinamide; Quality of Life; Severity of Illness Index; Treatment Outcome	2018

Article

Year

Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study.

Journal of Crohn's & colitis, 2018, Nov-09, Volume: 12, Issue:10

Topics: Adamantane; Administration, Oral; Adult; Biomarkers; C-Reactive Protein; Colitis, Ulcerative; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Intestinal Mucosa; Janus Kinase Inhibitors; Male; Middle Aged; Niacinamide; Quality of Life; Severity of Illness Index; Treatment Outcome

2018